Literature DB >> 2742226

Pancreaticoduodenectomy. The importance of preserving hepatic blood flow to prevent biliary fistula.

L W Traverso1, P C Freeny.   

Abstract

The arterial blood supply to the common bile duct must be preserved during pancreaticoduodenectomy to avoid ischemic breakdown of the biliary-enteric anastomosis. Interruption of this blood supply can occur during operation because of inadvertent division of the common hepatic artery or a hepatic artery variation. Approximately 17 per cent of patients have a hepatic artery variation that could contribute to devascularization of the common bile duct during surgical resection of the pancreatic head. This report discusses these hepatic artery variations and the value of angiography in defining hepatic arterial anatomy prior to surgery. Two cases are presented in which biliary-enteric anastomoses became ischemic and dehisced secondary to interruption of hepatic arterial blood flow.

Entities:  

Mesh:

Year:  1989        PMID: 2742226

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  32 in total

1.  Disposal of replaced common hepatic artery coursing within the pancreas during pancreatoduodenectomy: report of a case.

Authors:  Satoshi Yamamoto; Keiichi Kubota; Kyu Rokkaku; Takehiko Nemoto; Atsushi Sakuma
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  The implications of the presence of an aberrant right hepatic artery in patients undergoing a pancreaticoduodenectomy.

Authors:  Asif Jah; Neville Jamieson; Emmanuel Huguet; Raaj Praseedom
Journal:  Surg Today       Date:  2009-07-29       Impact factor: 2.549

3.  Aberrant right hepatic arterial anatomy and pancreaticoduodenectomy: recognition, prevalence and management.

Authors:  John A Stauffer; Mellena D Bridges; Naciye Turan; Justin H Nguyen; J Kirk Martin
Journal:  HPB (Oxford)       Date:  2009-03       Impact factor: 3.647

4.  Robotic pancreaticoduodenectomy in the presence of aberrant or anomalous hepatic arterial anatomy: safety and oncologic outcomes.

Authors:  Trang K Nguyen; Mazen S Zenati; Brian A Boone; Jennifer Steve; Melissa E Hogg; David L Bartlett; Herbert J Zeh; Amer H Zureikat
Journal:  HPB (Oxford)       Date:  2015-04-23       Impact factor: 3.647

5.  The coexistence of both replaced proper hepatic and gastroduodenal arteries due to the common hepatic artery absence.

Authors:  Konstantinos Natsis; Maria Piagkou; Nikolaos Lazaridis; Georgios Koimtzis; Stylianos Apostolidis
Journal:  Surg Radiol Anat       Date:  2017-05-15       Impact factor: 1.246

6.  Replaced common hepatic artery from the superior mesenteric artery: multidetector computed tomography (MDCT) classification focused on pancreatic penetration and the course of travel.

Authors:  Hong Il Ha; Min-Jeong Kim; Jihyun Kim; Sun-Young Park; Kwanseop Lee; Jang Yong Jeon
Journal:  Surg Radiol Anat       Date:  2016-01-12       Impact factor: 1.246

7.  Arterial resection for pancreatic cancer: a modern surgeon should change its behavior according to the new therapeutic options.

Authors:  E Vincente; Y Quijano; B Ielpo
Journal:  G Chir       Date:  2014 Jan-Feb

Review 8.  Management of the right hepatic artery in pancreaticoduodenectomy: a systematic review.

Authors:  Mehdi El Amrani; François-René Pruvot; Stéphanie Truant
Journal:  J Gastrointest Oncol       Date:  2016-04

9.  Totally replaced right hepatic artery in pancreaticoduodenectomy: is this anatomical condition a contraindication to minimally invasive surgery?

Authors:  Ji Hun Kim; Raquel Gonzalez-Heredia; Despoina Daskalaki; Mohammad Rashdan; Mario Masrur; Pier C Giulianotti
Journal:  HPB (Oxford)       Date:  2016-05-20       Impact factor: 3.647

10.  Outcome of concomitant resection of the replaced right hepatic artery in pancreaticoduodenectomy without reconstruction.

Authors:  Toshimichi Asano; Toru Nakamura; Takehiro Noji; Keisuke Okamura; Takahiro Tsuchikawa; Yoshitsugu Nakanishi; Kimitaka Tanaka; Soichi Murakami; Yuma Ebihara; Yo Kurashima; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Langenbecks Arch Surg       Date:  2018-01-23       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.